American Journal of Kidney Diseases
Volume 53, Issue 2 , Pages 192-196, February 2009

Is Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Combination Therapy Better Than Monotherapy and Safe in Patients With CKD?

  • Jeffrey S. Berns, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Jeffrey S. Berns, MD, University of Pennsylvania School of Medicine, Renal-Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, 3400 Spruce St, 1 Founders Pavilion, Philadelphia, PA 19104

University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

No abstract is available. To read the body of this article, please view the Full Text online.

 

PII: S0272-6386(08)01693-4

doi:10.1053/j.ajkd.2008.11.016

American Journal of Kidney Diseases
Volume 53, Issue 2 , Pages 192-196, February 2009

Article Tools